insights_auto
Why is ONCY up 2,31%?
Dive Deeperchevron_right
ONCY:NASDAQ
Oncolytics Biotech Inc
0,56 $
arrow_upward
+2,31%(+0,013) 1D
0,55 $
arrow_downward
-1,26% (-0,0070)bedtimeAfter hours
Closed: 9 қаз., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
0,55 $
High
0,57 $
Low
0,52 $
Mkt. cap
73,03 млн
Avg. vol.
1,05 млн
Volume
1,46 млн
52-wk high
1,32 $
52-wk low
0,52 $
Beta
1,15
Shares outstanding
127,51 млн
No. of employees
29
Open
0,55 $
High
0,57 $
Low
0,52 $
Mkt. cap
73,03 млн
Avg. vol.
1,05 млн
Volume
1,46 млн
52-wk high
1,32 $
52-wk low
0,52 $
Beta
1,15
Shares outstanding
127,51 млн
No. of employees
29
News stories
From web sources and news partners
Investing.com Nigeria
·
6 сағат бұрын
Form DEF 14A CG Oncology Inc For: 11 October By Investing.com
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc